Racura Oncology (FRA:FN3) Short Ratio


FRA:FN3 Racura Oncology Ltd FRA:FN3
13 GF Score
Price €1.23
View Full Analysis

What is Racura Oncology Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:FN3
13GF Score
Racura Oncology Ltd FRA:FN3
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Racura Oncology Business Description

Other Exchanges RAC:Australia
Address 1 Macquarie Place, Level 36, Gateway, Sydney, NSW, AUS, 2000
Racura Oncology Ltd is a developer of an oncology therapeutics platform designed to develop targeted cancer treatments. The company offers precision oncology drug development, biomarker-driven research, and cancer metabolism therapies, enabling healthcare providers and cancer patients to access targeted treatment options with improved therapeutic outcomes.
13GF Score

Get the complete analysis for FRA:FN3

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.23
Price